iSpecimen Inc. (ISPC) News
Filter ISPC News Items
ISPC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ISPC News Highlights
- ISPC's 30 day story count now stands at 6.
- Over the past 14 days, the trend for ISPC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- LI, MS and UL are the most mentioned tickers in articles about ISPC.
Latest ISPC News From Around the Web
Below are the latest news stories about ISPECIMEN INC that investors may wish to consider to help them evaluate ISPC as an investment opportunity.
Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ETNEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 25th at 8:15 A.M. ET Maxim Group LLC presents the Healthcare IT Virtual Conference. Participating companies focus on technology addressing rising health care costs, and scarcity of wo |
iSpecimen Appoints Eric Langlois as Chief Revenue OfficerMr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s Former SVP of Sales and Business DevelopmentLEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that it appointed Eric Langlois as Chief Revenue Officer, effective immediately. Mr. |
iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023. Ms. Curley will present at 5:00 p.m. ET. To attend, please register here. Fo |
iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on January 25, 2023LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023. Ms. Curley will present at 8:30 a.m. ET. To attend, please regi |
iSpecimen appoints CEO
|
iSpecimen Names Tracy Curley as Chief Executive OfficerPreviously Appointed Interim CEO in September 2022LEXINGTON, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately. “I am grateful to the Board and the entire team at iSpecimen for |
iSpecimen Appoints Joseph J. Basile to Board of DirectorsSought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimenLEXINGTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Joseph J. Basile to iSpecimen’s Board of Directors (the “Board”), as well |
iSpecimen Reports Third Quarter 2022 Financial and Operating Results- Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -LEXINGTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three- and nine-month period ended September 30, 2022. “During the third quarter of 2022, iSpecime |
Multiple insiders bought iSpecimen Inc. (NASDAQ:ISPC) stock earlier this year, a positive sign for shareholdersUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like... |
iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner NetworkNew Feature Provides Suppliers with Research Transparency to Optimize Fulfillment ProcessLEXINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, allowing supplier partners |